Skip to main content
SpringerLink
Log in

Circulating anti-tumor and autoantibodies in breast carcinoma: Relationship to stage and prognosis

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Serum antibodies to breast tumor antigen(s) and circulating autoantibodies were tested in 175 patients with various stages of carcinoma of the breast, followed for a mean period of 51 months. Antibodies to surface membrane and to cytoplasmic antigens of autologous and allogeneic tumor cells were measured. Peripheral lymphocyte count and skin reaction to six recall antigens were also tested.

Patients with metastatic disease had significantly lower prevalence of antibodies to autologous tumor cells and lower total lymphocyte count than patients with early breast cancer. Patients with locally advanced disease (⩾4 positive axillary nodes) had the highest frequency of anti-tumor antibodies, the second highest lymphocyte count, but with the lowest prevalance of autoantibodies. Presence or absence of anti-tumor or autoantibody did not correlate with results of skin tests or other standard blood tests. Among patients with locally advanced or metastatic breast cancer, those who had a positive skin test or whose lymphocyte count was 1500 to 2500 per cu mm had significantly better 5-year absolute survival rates (p = 0.04, p = 0.002, respectively).

This study suggests that in patients with locally advanced or metastatic breast cancers, skin test reactivity and optimal peripheral lymphocyte count may be useful prognostic indicators. In contrast, neither the presence of anti-tumor antibodies to membrane or cytoplasmic antigens, nor the presence of autoantibodies, correlates with prognosis in patients with early or late breast cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Avis F, Avis I, Newsome JF, Haughton G: Antigenic crossreactivity between adenocarcinoma of the breast and fibrocystic disease of the breast. J Natl Cancer Inst 56:17–25, 1976

    PubMed  Google Scholar 

  2. Ayeni RO, Tataryn DN, MacFarlane JK, Thomson DMP: A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: A review of two years' experience. Surgery 87:380–389, 1980

    PubMed  Google Scholar 

  3. Black MM, Zachrau RE, Shore B, Dion AS, Leis HP: Cellular immunity to autologous breast cancer and RIII-Murine mammary tumor virus preparations. Cancer Res 38:2068–2076, 1978

    PubMed  Google Scholar 

  4. Dean JH, McCoy JL, Cannon GB, et al.: Cell-mediated immune responses of breast cancer patients to autologous tumor-associated antigens. J Natl Cancer Inst 58:549–555, 1977

    PubMed  Google Scholar 

  5. Fodor J: Peripheral blood lymphocyte counts and survival in breast cancer. Neoplasma 23:311–313, 1976

    PubMed  Google Scholar 

  6. Franks CR, Williams Y: Prognostic value of peripheral lymphocyte count in hormone therapy or advanced breast cancer. Br J Cancer 34:641–644, 1976

    PubMed  Google Scholar 

  7. Fujisawa T, Waldman SR, Yenemoto RH: Leukocyte adherence inhibition by soluble tumor antigens in breast cancer patients. Cancer 39:506–513, 1977.

    PubMed  Google Scholar 

  8. Heppner GH: Immunology.In St. Arneault G, Band P, Israel L (eds): Breast Cancer: A Multidisciplinary Approach. Springer Verlag, New York, 1976, pp. 95–108.

    Google Scholar 

  9. Hoffken K, Meredith ID, Robins RA, et al.: Circulating immune complexes in patients with breast cancer. Br Med J 2:218–220, 1977

    PubMed  Google Scholar 

  10. Holmes FF, Fields MD: Lymphocytes and breast cancer: Relationship of blood lymphocyte count to survival in breast cancer. J Kansas Med Soc 3/71 issue, pp 135–137.

  11. Holt JE, Lee Y-TN: Peripheral lymphocyte counts and results of therapeutic castration for advanced breast cancer. Ann Surg 175:403–408, 1972

    PubMed  Google Scholar 

  12. Humphrey LJ, Estes NC, Morse PA, et al.: Serum antibody in patients with mammary disease. Cancer 34:1516–1520, 1974

    PubMed  Google Scholar 

  13. Lee E, Desu M: A computer program for comparing K sample with right-censored data. Computer Programs in Biomedicine 2:315–321, 1972

    PubMed  Google Scholar 

  14. Lee Y-TN: Delayed cutaneous hypersensitivity, lymphocyte count, and blood tests in patients with breast carcinoma. J Surg Oncol 27:135–140, 1984

    PubMed  Google Scholar 

  15. Lee Y-TN, Chan LS: Surgical treatment of carcinoma of the breast: II. Prognostic factors influencing relapse rate. J Surg Oncol 25: 102–108, 1984

    PubMed  Google Scholar 

  16. Lee Y-TN, Sparks FC, Eilber FR, et al.: Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer. Cancer 35:748–755, 1975.

    PubMed  Google Scholar 

  17. Lerner MP, Anglin JH, Nordquist RE: Cell-surface antigens from human breast tumor cells. J Natl Cancer Inst 60:39–44, 1978.

    PubMed  Google Scholar 

  18. Lewis MG, Phillips TM, Rowden G, Jerry LM: Humoral immune factors in metastasis in human cancer.In Day SB (ed): Cancer Invasion and Metastasis: Biologic Mechanisms and Therapy. Raven Press, New York, 1977, pp. 245–258

    Google Scholar 

  19. Lopez M, O'Connor R, MacFarlane JK, Thomson DMP: The natural history of antitumor immunity in human breast cancer assayed by tube leucocyte adherence inhibition. Br J Cancer 38:660–673, 1978

    PubMed  Google Scholar 

  20. Meyer KK, Boswelli BD, Weaver DR, et al.: Cellular immune response to mastectomy and radiation. Guthrie Clin Bull 40:48–61, 1970

    Google Scholar 

  21. Pardridge DH, Wang BS, Mannick JA, Deckers PJ: Specificity of immune paralysis at large tumor volumes. Surgical Forum 26:118–119, 1975

    PubMed  Google Scholar 

  22. Priori ES, Seman G, Dmochowski L, Gallager HS, Anderson DE: Immunofluorescence studies on sera of patients with breast carcinoma. Cancer 28:1462–1471, 1971

    PubMed  Google Scholar 

  23. Ramey WG, Fitzpatrick HF, Hashim GA, et al.: Diagnosis, stage, and prognosis of lung carcinoma by preoperative assay of lung tumor antigen-sensitive T lymphocytes. J Thorac Cardiovasc Surg 80:656–660, 1980

    PubMed  Google Scholar 

  24. Riesco A: Five-year cancer cure. Cancer 25:135–140, 1970

    PubMed  Google Scholar 

  25. Sanner T, Brennhovd I, Christensen I, Jorgensen O, Kvaloy S: Cellular antitumor immune response in women with risk factors for breast cancer. Cancer Res 39:654–657, 1979

    PubMed  Google Scholar 

  26. Sheikh KMA, Quismorio FP, Friou GJ, Lee Y-TN: Ductular carcinoma of the breast: Serum antibodies to tumorassociated antigens. Cancer 44:2083–2089, 1979

    PubMed  Google Scholar 

  27. Teasdale C, Thatcher J, Whitehead RH, Chare MJB, Hughes LE: T and B lymphocytes in breast cancer. Lancet i:543–544, 1977

    Google Scholar 

  28. Turnbull AR, Turner DTL, Fraser JD, Lloyd RS, Lange CJ, Wright R: Autoantibodies in early breast cancer: A stage-related phenomenon? Br J Cancer 38:461–463, 1978

    PubMed  Google Scholar 

  29. Vose BM, Hughes R, Bazill GW: Failure of leucocyteadherence-inhibition assays to discriminate between benign and malignant breast diseases. Br J Cancer 40:954–956, 1979

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. Yeu-Tsu Margaret Lee

    Present address: Dept. of Surgery, Tripler Army Medical Center, 96859, Honolulu, HI, USA

Authors and Affiliations

  1. From the Department of Surgery, University of Southern California School of Medicine, 90033, Los Angeles, California, USA

    Yeu-Tsu Margaret Lee & Khalid M. A. Sheikh

  2. From the Department of Medicine (Clinical Immunology and Rheumatology Section), University of Southern California School of Medicine, 90033, Los Angeles, California, USA

    Francisco P. Quismorio Jr. & George J. Friou

Authors
  1. Yeu-Tsu Margaret Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Khalid M. A. Sheikh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francisco P. Quismorio Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. George J. Friou
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, YT.M., Sheikh, K.M.A., Quismorio, F.P. et al. Circulating anti-tumor and autoantibodies in breast carcinoma: Relationship to stage and prognosis. Breast Cancer Res Tr 6, 57–65 (1985). https://doi.org/10.1007/BF01806011

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806011

Key words

Search

Navigation